D008415DisordersC04.557.450.565.465C17.800.508C20.543.520.350220.998564MastocytosisFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.1817320.1056732research area of0.7279730.019030611subject area for31476322Weiler CR, Austen KF, Akin C, Barkoff MS, Bernstein JA, Bonadonna P, Butterfield JH, Carter M, Fox CC, Maitland A, Pongdee T, Mustafa SS, Ravi A, Tobin MC, Vliagoftis H, Schwartz LBThe Journal of allergy and clinical immunologyAAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. 2019 10; 144(4):883-896.J Allergy Clin Immunol2019-08-30T00:00:002019AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management.MehmetAltintasMehmet Altintas349147Altintas, MehmetAssociate ProfessorMaryTobinMary Tobin349573Tobin, MaryAssistant Professor6Assistant Professor5Associate ProfessorInternal MedicineRush University, Rush Medical College9990072Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, Heitjan D, Ma YProceedings of the National Academy of Sciences of the United States of AmericaActivating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1609-14.Proc Natl Acad Sci U S A1999-02-16T00:00:001999Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.11705354Tharp MD, Longley BJDermatologic clinicsMastocytosis. Dermatol Clin. 2001 Oct; 19(4):679-96, viii-ix.Dermatol Clin2001-10-01T00:00:002001Mastocytosis.23777495Chan IJ, Kasprowicz S, Tharp MDClinical and experimental dermatologyDistinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis. Clin Exp Dermatol. 2013 Jul; 38(5):538-44.Clin Exp Dermatol2013-07-01T00:00:002013Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis.true1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate ProfessorInternal Medicine, Division of Nephrology29350409Chan IJ, Tharp MDClinical and experimental dermatologyComparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis. Clin Exp Dermatol. 2018 Jun; 43(4):416-422.Clin Exp Dermatol2018-01-19T00:00:002018Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.